Osteoarthritis (OA), also known as a degenerative joint disease (DJD), is the most common type of arthritis, affecting millions of people worldwide. It occurs when the protective cartilage that cushions the ends of the bones wear down over time.
Although osteoarthritis can damage any joint in the body, the disorder most commonly affects joints in the hands, knees, hips, and spine and is more likely to develop as people age, although it can occur in adults of any age.
<a href="https://www.delveinsight.com/report-store/osteoarthritis-epidemiology-forecast">Osteoarthritis Epidemiology Segmentation</a> in the 7MM
<ul>
<li>Joint-site specific prevalent cases of osteoarthritis</li>
<li>Severity-specific&nbsp; prevalent cases of osteoarthritis</li>
<li>Prevalent Cases of Osteoarthritis</li>
<li>Age-Specific Prevalent Cases of Osteoarthritis</li>
<li>Gender-specific Diagnosed Prevalent Cases of Osteoarthritis</li>
</ul>
&nbsp;
Osteoarthritis Epidemiological Insights Observed in the 7MM (2021)
The total diagnosed cases of Osteoarthritis observed in the 7MM were observed to be 83 Million in the year 2021
<a href="https://www.delveinsight.com/report-store/osteoarthritis-market">Osteoarthritis Market Insight</a>
The Osteoarthritis Market size is anticipated to grow with a significant CAGR during the study period 2019-32.
&nbsp;
Osteoarthritis Market Strengths
Single injection joint function enhancing hyaluronic acid formulations sales are steadily rising, and companies are looking to expand into new markets in order to increase their profit of their single injection products.
Osteoarthritis Market Opportunities
Lucrative opportunities in nations where single-injection joint function enhancing drugs are unavailable. The growth of the market is driven by an increase in the geriatric population and obesity.
&nbsp;
<a href="https://www.delveinsight.com/report-store/osteoarthritis-pipeline-insight">Osteoarthritis Emerging Drugs</a>
The emerging drugs in the Osteoarthritis market are
<ul>
<li>LNA043</li>
<li>AMPION</li>
<li>TLC599</li>
<li>CNTX-4975</li>
<li>LORECIVIVINT (SM04690)</li>
<li>RENU (AMNIOTIC SUSPENSION ALLOGRAFT)</li>
<li>INVOSSA (TG-C)</li>
<li>WEGOVY (SEMAGLUTIDE)</li>
<li>JOINTSTEM</li>
<li>X0002</li>
<li>RTX (RESINIFERATOXIN)</li>
<li>SPRIFERMIN</li>
<li>APPA</li>
<li>CARTISTEM</li>
<li>MIV-711, and others</li>
</ul>
Osteoarthritis Key Players&nbsp;
The key players working in the Osteoarthritis market are
<ul>
<li>NOVARTIS</li>
<li>AMPIO PHARMACEUTICALS&nbsp;</li>
<li>TAIWAN LIPOSOME COMPANY&nbsp;</li>
<li>CENTREXION THERAPEUTICS&nbsp;</li>
<li>BIOSPLICE THERAPEUTICS</li>
<li>ORGANOGENESIS</li>
<li>KOLON TISSUEGENE</li>
<li>NOVO NORDISK</li>
<li>NATURE CELL</li>
<li>TECHFIELDS PHARMA</li>
<li>SORRENTO THERAPEUTICS</li>
<li>MERCK KGAA/TRIALSPARK</li>
<li>AKL RESEARCH AND DEVELOPMENT</li>
<li>MEDIPOST</li>
<li>MEDIVIR, and others</li>
</ul>

Osteoarthritis Market 

Osteoarthritis Market Infographics 

Osteoarthritis Market levodopa-induced dyskinesia MarketSymptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape